TSXV:TRL.H - Post by User
Post by
gatmanon Jun 15, 2017 7:06pm
225 Views
Post# 26368759
Gynoflor
Gynoflorawaiting licencing...if approved, this product could be huge, as there is nothing like it on the Rx market in Canada...will help many thousands of female patients with a very painful, often chronic and irritating conditon for which at the present time, there is no really effective treatment on the market here in Canada.
I think with the proper marketing, Gynoflor could take this stock well, well over $1. It could be bigger than the testosterone gel niche, IMHO.
Technically speaking, the chart of ASP is in gear and a gain of almost thirty percent in the last week alone, you have to keep an eye on this one.
Interesting how this company is re-inventing itself to meet, shall we say very personal and often unmet needs. Keep an eye on it.